To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.

Died in Committee

Referred to the House Committee on Energy and Commerce.

Sponsor

Nikki Budzinski

Democrat - IL

Take Action

This bill has been ignored for 501 days. Add your name and contact the people responsible.

Copy the letter, then paste it into an email or the representative's contact form. Your voice matters.